Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...
Treatment of metastatic prostate cancer with androgen ablation often elicits dramatic tumor regressions, but the response is rarely complete, making clinical recurrence inevitable with time.
Journal of Clinical Oncology: “Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer.” Health and ...
Radiofrequency ablation. The doctor uses catheters to send radiofrequency energy (similar to microwave heat) that makes circular scars around each vein or group of veins. Cryoablation.
As the authors note in this report, a longer time to PSA progression seems to occur after two courses of androgen ablation, which might correspond to the time for the evolution of resistance to ...
Laser ablation is one of the best alternatives to invasive procedures like craniotomies (temporarily removing a piece of the skull to access the brain during surgery). Laser ablation is extremely ...
Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...
A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing radiotherapy ...
Fatigue after a cardiac ablation (also called catheter or radiofrequency ablation) is normal and can be expected for two days ...
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique ...
Hosted on MSN14d
What Is an Ablation?
An ablation is a minimally invasive surgical procedure that involves using extreme heat, cold, or lasers to create scar tissue or remove unwanted growths. This procedure can treat a range of ...
Table I displays demographic, disease and treatment information for the whole cohort based on androgen ablation. Table II displays the characteristics of the EBRT and no-EBRT subgroups.